Title:
STEM CELL ENHANCING THERAPEUTICS
Document Type and Number:
WIPO Patent Application WO/2014/028668
Kind Code:
A3
Abstract:
The present application disclose a method for treating a patient who would benefit from stimulation of the patient's stem cells, comprising administering to the patient an antibody that specifically binds to an epitope of the MUCl protein expressed on human undifferentiated stem cells.
Inventors:
BAMDAD CYNTHIA (US)
Application Number:
PCT/US2013/055015
Publication Date:
May 01, 2014
Filing Date:
August 14, 2013
Export Citation:
Assignee:
MINERVA BIOTECHNOLOGIES CORP (US)
International Classes:
A61K39/395; C12N5/00; C12N5/02
Domestic Patent References:
| WO2008070171A2 | 2008-06-12 | |||
| WO2008101231A2 | 2008-08-21 | |||
| WO1991009134A1 | 1991-06-27 |
Foreign References:
| US20100316688A1 | 2010-12-16 | |||
| EP2329822A1 | 2011-06-08 | |||
| US7825092B2 | 2010-11-02 |
Other References:
BRUGGER, W ET AL.: "Expression Of MUC-1 Epitopes On Normal Bone Marrow: Implications For The Detection of Micrometastatic Tumor Cells.", JOURNAL OF CLINICAL ONCOLOGY., vol. 17, no. 5, May 1999 (1999-05-01), pages 1535 - 1535, XP002466551
IKEZOE, T ET AL.: "A Novel Treatment Strategy Targeting Aurora Kinases In Acute Myelogenous Leukemia.", MOLECULAR CANCER THERAPEUTICS, vol. 6, no. 6, 31 May 2007 (2007-05-31), pages 1851 - 1857, XP055197792
IKEZOE, T ET AL.: "A Novel Treatment Strategy Targeting Aurora Kinases In Acute Myelogenous Leukemia.", MOLECULAR CANCER THERAPEUTICS, vol. 6, no. 6, 31 May 2007 (2007-05-31), pages 1851 - 1857, XP055197792
Attorney, Agent or Firm:
KIM, Joseph, Hyosuk (P.O. Box 1078La Canada, CA, US)
Download PDF: